1. Pathological complete response to chemotherapy in pancreatic cancer: frequency, predictors and impact on overall survival. (March 2018) Authors: Azab, B.; Ripat, C.; Amundson, J.; Macedo, F.I.; Picado, O.; Livingstone, A.S.; Yakoub, D. Journal: HPB Issue: Volume 20(2018)Supplement 1 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Practice patterns and long-term outcomes among patients with pancreatic giant cell tumors. (March 2019) Authors: Macedo, F.I.; Cass, S.H.; Azab, B.; Song, N.; Yakoub, D.; Livingstone, A.S.; Merchant, N.B. Journal: HPB Issue: Volume 21(2019)Supplement 1 Page Start: S179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Racial disparities in survival among patients with resected pancreatic adenocarcinoma and pancreatic neuroendocrine tumor. Miami-based population study. (March 2018) Authors: Azab, B.; Yakoub, D. Journal: HPB Issue: Volume 20(2018)Supplement 1 Page Start: S130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Revision of nationwide practice patterns in the management of T2 gallbladder carcinoma. (March 2018) Authors: Macedo, F.I.; Kutlu, O.C.; Allen, C.J.; Azab, B.; Yakoub, D.; Dudeja, V.; Merchant, N.B. Journal: HPB Issue: Volume 20(2018)Supplement 1 Page Start: S62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The impact of neoadjuvant therapy vs. upfront surgery on margin-negative resection rate and overall survival among intrahepatic cholangiocarcinoma patients. (March 2019) Authors: Azab, B.; Macedo, F.I.; Ripat, C.; Hoefer, R.; Guye, M.; Livingstone, A.S.; Yakoub, D. Journal: HPB Issue: Volume 21(2019)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The role of pretreatment neutrophil/lymphocyte ratio in predicting survival in pancreatic cancer patients based on neoadjuvant chemotherapy pathological response. (March 2018) Authors: Azab, B.; Amundson, J.; Estfanous, N.; Macedo, F.I.; Merchant, N.; Yakoub, D. Journal: HPB Issue: Volume 20(2018)Supplement 1 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗